305 results on '"Holzgreve, Adrien"'
Search Results
2. [68Ga]Ga-FAPI-46 PET/CT for penile cancer – a feasibility study
3. Implementation of PET/CT in radiation oncology—a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology
4. Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome
5. Young Oncologists United (YOU) als interdisziplinäre Nachwuchsarbeitsruppe der DKG gegründet
6. Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial.
7. Prognostic significance of pretreatment PET parameters in inoperable, node-positive NSCLC patients with poor prognostic factors undergoing hypofractionated radiotherapy: a single-institution retrospective study
8. Patterns of intersectional tumor volumes in T2-weighted MRI and [18F]FET PET in adult glioma: a prospective, observational study
9. PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancer
10. [68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis
11. New Radiopharmaceuticals for Brain Tumors Imaging
12. Therapiemonitoring der neoadjuvanten Radio‑/Chemotherapie
13. Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE
14. Importance of interdisciplinarity in modern oncology: results of a national intergroup survey of the Young Oncologists United (YOU)
15. Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)
16. Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages
17. Neu gegründet – die nuklearmedizinische „Young DGN“ stellt sich vor: Eine Arbeitsgemeinschaft der Deutschen Gesellschaft für Nuklearmedizin e. V. (DGN)
18. A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [18F]FDG PET/CT
19. Aktuelle nuklearmedizinische Entwicklungen beim fortgeschrittenen Nierenzellkarzinom
20. Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patients
21. Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
22. Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment
23. TSPO PET signal using [18F]GE180 is associated with survival in recurrent gliomas
24. Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma
25. In response to: PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary
26. Case 25: Primary Diagnosis of an Isocitrate Dehydrogenase (IDH) Wild-Type Glioma
27. Divergent Findings in the Diagnosis of ATTR-CM Using Common Cardiac Diagnostics and 99mTc-DPD Scintigraphy
28. Feasibility of radiomic feature harmonization for pooling of [18F]FET or [18F]GE-180 PET images of gliomas
29. A randomized phase 2 trial in progress of flexible and extended dosing of 177Lu-PSMA-617 molecular radioligand therapy in mCRPC (FLEX-MRT).
30. Correction to: Next‑generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR‑targeting peptide [18F]SiTATE
31. Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma
32. PET/CT for Target Delineation of Lung Cancer Before Radiation Therapy
33. Case 32: Suspected Recurrence of Brain Metastasis After Radiotherapy
34. Case 27: Meningioma with Difficult Delineation on MRI
35. Deep learning based time-to-event analysis with PET, CT and joint PET/CT for head and neck cancer prognosis
36. 18F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
37. Patterns of intersectional tumor volumes in T2-weighted MRI and [18F]FET PET in adult glioma: a prospective, observational study.
38. [68Ga]Ga-FAPI-46 PET/CT for penile cancer – a feasibility study.
39. Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics
40. 68Ga-EMP-100 PET/CT—a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer
41. Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
42. Case 32: Suspected Recurrence of Brain Metastasis After Radiotherapy
43. Case 27: Meningioma with Difficult Delineation on MRI
44. Case 25: Primary Diagnosis of an Isocitrate Dehydrogenase (IDH) Wild-Type Glioma
45. The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic Glioblastoma
46. Dummy Run for Planning of Isotoxic Dose-Escalated Radiation Therapy for Glioblastoma Used in the Pride Trial (Noa-28; Aro-2024-01; Ag-Nro-06)
47. Primäre und sekundäre Lebertumore – aus Sicht der Nuklearmedizin
48. Toward the future of nuclear medicine: How young professionals are getting involved and what plans they have.
49. FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls
50. [68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.